Increased cerebrospinal fluid cAMP levels in Alzheimer's disease. (Q53337897)

13 May 2018

title

Increased cerebrospinal fluid cAMP levels in Alzheimer's disease. (English)

1 reference

13 May 2018

0 references

Martínez M

1

1 reference

13 May 2018

Fernández E

2

1 reference

13 May 2018

Frank A

3

1 reference

13 May 2018

Guaza C

4

1 reference

13 May 2018

de la Fuente M

5

1 reference

13 May 2018

Hernanz A

6

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 November 1999

1 reference

13 May 2018

number of pages

3

1 reference

based on heuristic

inferred from page(s)

published in

Brain Research

1 reference

13 May 2018

volume

846

1 reference

13 May 2018

page(s)

265-267

1 reference

13 May 2018

issue

2

1 reference

13 May 2018

Abnormal phosphorylation of tau precedes ubiquitination in neurofibrillary pathology of Alzheimer disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901981-2

Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901981-2

cAMP-dependent protein kinase in cerebral microvessels in aging and Alzheimer disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901981-2

Intracellular cyclic AMP inhibits constitutive and phorbol ester-stimulated secretory cleavage of amyloid precursor protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901981-2

Increased accumulation of cAMP in cerebral microvessels in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901981-2

Stimulation of amyloid precursor protein synthesis by adrenergic receptors coupled to cAMP formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901981-2

A68: a major subunit of paired helical filaments and derivatized forms of normal Tau.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901981-2

Tau protein is phosphorylated by cyclic AMP-dependent protein kinase and calcium/calmodulin-dependent protein kinase II within its microtubule-binding domains at Ser-262 and Ser-356.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901981-2

Cultured cells as a screen for novel treatments of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901981-2

Altered phosphorylation of tau protein in heat-shocked rats and patients with Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901981-2

Effects of Alzheimer's disease and normal aging on cerebrospinal fluid norepinephrine responses to yohimbine and clonidine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901981-2

Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901981-2

Altered metabolic properties of cultured skin fibroblasts in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901981-2

Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901981-2

10.1016/S0006-8993(99)01981-2

7 January 2021

Identifiers

DOI

1 reference

13 May 2018

PubMed ID

10556645

1 reference

13 May 2018